Newsletter
PCSK9 inhibitors and statin intolerance, pembrolizumab for melanoma, CDC opioid prescribing guideline, and more

JAMA Editor’s Summary

PCSK9 inhibitors and statin intolerance, pembrolizumab for melanoma, CDC opioid prescribing guideline, and more

Editor's Audio Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the
April 19, 2016

PCSK9 inhibitors and statin intolerance, pembrolizumab for melanoma, CDC opioid prescribing guideline, and more

Editor’s Audio Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the April 19, 2016 issue

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

We gratefully acknowledge the many organizations that have generously supported our podcasts and platform.

Network Sponsors and Advertisers

Event and Media Partners

Buffer LinkedIn WhatsApp